Amelioration of sexual adverse effects in the early breast cancer patient

por Melisko, Michelle E., Goldman, Mindy, Rugo, Hope S.
Publicado 2010

The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study

por Abel, Mary Kathryn, Shui, Amy M., Chien, A. Jo, Rugo, Hope S., Melisko, Michelle, Baehner, Frederick, Mukhtar, Rita A.
Publicado 2022

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid

por Vidula, Neelima, Greenberg, Sally, Petrillo, Laura, Hwang, Jimmy, Melisko, Michelle, Goga, Andrei, Moasser, Mark, Magbanua, Mark, Park, John W., Rugo, Hope S.
Publicado 2021

Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer

por Record, Helena, Clelland, Elle, Rothschild, Harriet T., Kaur, Mandeep, Chien, A. Jo, Melisko, Michelle, Rugo, Hope S., Mujir, Firdows, Huppert, Laura, Mukhtar, Rita A.
Publicado 2023

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

por Lorizio, Wendy, Rugo, Hope, Beattie, Mary S, Tchu, Simone, Melese, Teri, Melisko, Michelle, Wu, Alan HB, Lawrence, H Jeffrey, Nikoloff, Michele, Ziv, Elad
Publicado 2011

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors

por Miaskowski, Christine, Topp, Kimberly, Conley, Yvette P., Paul, Steven M., Melisko, Michelle, Schumacher, Mark, Chesney, Margaret, Abrams, Gary, Levine, Jon D., Kober, Kord M.
Publicado 2019

LPTO-05. FACTORS INFLUENCING RISK OF LEPTOMENINGEAL METASTASIS IN BREAST CANCER PATIENTS RECEIVING STEREOTACTIC RADIOSURGERY FOR LIMITED BRAIN METASTASES

por Zhang, Michael, Chan, Jason, Xu, Chelsea, Anderson, August, Lazar, Ann, Villanueva-Meyer, Javier, McDermott, Mike, Melisko, Michelle, Sneed, Penny, Morin, Olivier, Braunstein, Steve
Publicado 2019

Survivorship wellness: a multidisciplinary group program for cancer survivors

por Siwik, Chelsea J., Jhaveri, Kinnari, Cohen, Jamie Alexis, Barulich, Mikela, Chang, Alison, Levin, Anna O., Goyal, Neha G., Melisko, Michelle, Chesney, Margaret A., Shumay, Dianne
Publicado 2023

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

por Abel, Mary Kathryn, Shui, Amy M., Melisko, Michelle, Chien, A. Jo, Yoshida, Emi J., Lancaster, Elizabeth M., Van ‘T Veer, Laura, Esserman, Laura J., Mukhtar, Rita A.
Publicado 2021

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer

por Rugo, Hope S., Campone, Mario, Amadori, Dino, Aldrighetti, Daniela, Conte, PierFranco, Wardley, Andrew, Villanueva, Cristian, Melisko, Michelle, McHenry, M. Brent, Liu, David, Lee, Francis, Pivot, Xavier
Publicado 2013

Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors

por Magbanua, Mark Jesus M., Roy, Ritu, Sosa, Eduardo V., Hauranieh, Louai, Kablanian, Andrea, Eisenbud, Lauren E., Ryazantsev, Artem, Au, Alfred, Scott, Janet H., Melisko, Michelle, Park, John W.
Publicado 2014

Evaluation of the Pathways for Survivors Program to Address Breast Cancer Survivorship–Associated Distress: Survey Study

por Umashankar, Saumya, Mamounas, Matina Elise, Matthys, Madeline, Hadeler, Edward Kenji, Wong, Emily Claire, Hicks, Greg, Hwang, Jimmy, Chien, Amy Jo, Rugo, Hope S, Hamolsky, Deborah, Esserman, Laura, Melisko, Michelle
Publicado 2022

Pre-Surgery Demographic, Clinical, and Symptom Characteristics Associated with Different Self-Reported Cognitive Processes in Patients with Breast Cancer

por Allemann-Su, Yu-Yin, Vetter, Marcus, Koechlin, Helen, Paul, Steven M., Cooper, Bruce A., Oppegaard, Kate, Melisko, Michelle, Levine, Jon D., Conley, Yvette, Miaskowski, Christine, Katapodi, Maria C.
Publicado 2022

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

por Abel, Mary Kathryn, Melisko, Michelle E., Rugo, Hope S., Chien, A. Jo, Diaz, Italia, Levine, Julia K., Griffin, Ann, McGuire, Joseph, Esserman, Laura J., Borno, Hala T., Mukhtar, Rita A.
Publicado 2021

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

por Terranova-Barberio, Manuela, Pawlowska, Nela, Dhawan, Mallika, Moasser, Mark, Chien, Amy J., Melisko, Michelle E., Rugo, Hope, Rahimi, Roshun, Deal, Travis, Daud, Adil, Rosenblum, Michael D., Thomas, Scott, Munster, Pamela N.
Publicado 2020

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

por Malani, Rachna, Fleisher, Martin, Kumthekar, Priya, Lin, Xuling, Omuro, Antonio, Groves, Morris D., Lin, Nancy U., Melisko, Michelle, Lassman, Andrew B., Jeyapalan, Suriya, Seidman, Andrew, Skakodub, Anna, Boire, Adrienne, DeAngelis, Lisa M., Rosenblum, Marc, Raizer, Jeffrey, Pentsova, Elena
Publicado 2020

Fully Automated Echocardiogram Interpretation in Clinical Practice: Feasibility and Diagnostic Accuracy

por Zhang, Jeffrey, Gajjala, Sravani, Agrawal, Pulkit, Tison, Geoffrey H., Hallock, Laura A., Beussink-Nelson, Lauren, Lassen, Mats H., Fan, Eugene, Aras, Mandar A., Jordan, ChaRandle, Fleischmann, Kirsten E., Melisko, Michelle, Qasim, Atif, Shah, Sanjiv J., Bajcsy, Ruzena, Deo, Rahul C.
Publicado 2018

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

por Vahdat, Linda T., Schmid, Peter, Forero-Torres, Andres, Blackwell, Kimberly, Telli, Melinda L., Melisko, Michelle, Möbus, Volker, Cortes, Javier, Montero, Alberto J., Ma, Cynthia, Nanda, Rita, Wright, Gail S., He, Yi, Hawthorne, Thomas, Bagley, Rebecca G., Halim, Abdel-Baset, Turner, Christopher D., Yardley, Denise A.
Publicado 2021

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

por Anders, Carey, Deal, Allison M., Abramson, Vandana, Liu, Minetta C., Storniolo, Anna M., Carpenter, John T., Puhalla, Shannon, Nanda, Rita, Melhem-Bertrandt, Amal, Lin, Nancy U., Kelly Marcom, P., Van Poznak, Catherine, Stearns, Vered, Melisko, Michelle, Smith, J. Keith, Karginova, Olga, Parker, Joel, Berg, Jonathan, Winer, Eric P., Peterman, Amy, Prat, Aleix, Perou, Charles M., Wolff, Antonio C., Carey, Lisa A.
Publicado 2014

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

por Freedman, Rachel A., Gelman, Rebecca S., Anders, Carey K., Melisko, Michelle E., Parsons, Heather A., Cropp, Anne M., Silvestri, Kelly, Cotter, Christine M., Componeschi, Kathryn P., Marte, Juan M., Connolly, Roisin M., Moy, Beverly, Van Poznak, Catherine H., Blackwell, Kimberly L., Puhalla, Shannon L., Jankowitz, Rachel C., Smith, Karen L., Ibrahim, Nuhad, Moynihan, Timothy J., O’Sullivan, Ciara C., Nangia, Julie, Niravath, Polly, Tung, Nadine, Pohlmann, Paula R., Burns, Robyn, Rimawi, Mothaffar F., Krop, Ian E., Wolff, Antonio C., Winer, Eric P., Lin, Nancy U.
Publicado 2019